DHR vs MSFT: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Microsoft Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Microsoft Corporation · Technology
$429.25
+23.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
MSFT has more upside to fair value
(+23.0%).
MSFT trades at a lower forward P/E
(26.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MSFT |
| Current Price |
$174.04 |
$429.25 |
| Fair Value Estimate |
$197.01 |
$527.78 |
| Upside to Fair Value |
+13.2%
|
+23.0%
|
| Market Cap |
$123.2B |
$3,187.4B |
| Forward P/E |
33.4x
|
26.8x
|
| EV / EBITDA |
20.3x
|
17.2x
|
| Price / Sales |
5.0x
|
10.4x
|
| Price / FCF |
23.3x
|
41.2x
|
| Revenue Growth YoY |
+3.7%
|
+16.7%
|
| Gross Margin |
60.7%
|
68.6%
|
| Operating Margin |
21.0%
|
46.7%
|
| Return on Equity |
7.1%
|
33.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
2.43%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Microsoft Corporation is a leading technology company specializing in software infrastructure, cloud computing, and productivity solutions. The company benefits from a high-quality business model characterized by durable competitive moats including strong switching costs and intangible assets such as its brand and cloud infrastructure. Under CEO Satya Nadella's leadership since 2014, Microsoft ha…
Accumulation Zones
| Metric |
DHR |
MSFT |
| Zone Low |
$147.76 |
$395.83 |
| Zone High |
$167.46 |
$448.61 |
| In Buy Zone? |
No
|
Yes
|